Pages that link to "Q39232014"

The following pages link to An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. (Q39232014):

Displaying 29 items.

• A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling. (Q38656290) (← links)
• Metabolic cardiomyopathies - fighting the next epidemic (Q42050369) (← links)
• Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats (Q43375903) (← links)
• Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment. (Q47104911) (← links)
• Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms (Q49833824) (← links)
• Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes (Q50074042) (← links)
• Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets (Q50089724) (← links)
• [Irbesartan ameliorates cardiac inflammation in type 2 diabetic db/db mice]. (Q50698161) (← links)
• Recent novel approaches to limit oxidative stress and inflammation in diabetic complications. (Q54956778) (← links)
• Long noncoding RNAs: A new player in the prevention and treatment of diabetic cardiomyopathy? (Q57166896) (← links)
• The Role of Allograft Inflammatory Factor-1 in the Effects of Experimental Diabetes on B Cell Functions in the Heart (Q58749956) (← links)
• Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients (Q59813541) (← links)
• Dietary Advanced Glycation Endproducts Induce an Inflammatory Response in Human Macrophages in Vitro (Q60921753) (← links)
• Oral Plaque from Type 2 Diabetic Patients Reduces the Clonogenic Capacity of Dental Pulp-Derived Mesenchymal Stem Cells (Q61818463) (← links)
• The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes (Q64249614) (← links)
• Simvastatin Improves Cardiac Hypertrophy in Diabetic Rats by Attenuation of Oxidative Stress and Inflammation Induced by Calpain-1-Mediated Activation of Nuclear Factor-κB (NF-κB) (Q64265038) (← links)
• FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway (Q64279169) (← links)
• Myeloid differentiation protein 1 protected myocardial function against high-fat stimulation induced pathological remodelling (Q64374615) (← links)
• Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy (Q89547353) (← links)
• Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence (Q89811716) (← links)
• Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives (Q90163590) (← links)
• Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model (Q90360002) (← links)
• Methylsulfonylmethane decreases inflammatory response to tumor necrosis factor-α in cardiac cells (Q90431614) (← links)
• Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-κB-Mediated Inflammation (Q90477908) (← links)
• The Effects of Folic Acid Administration on Cardiac Oxidative Stress and Cardiovascular Biomarkers in Diabetic Rats (Q91907454) (← links)
• Application and Mechanisms of Triptolide in the Treatment of Inflammatory Diseases-A Review (Q92187969) (← links)
• Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway (Q92313923) (← links)
• Immunometabolic cross-talk in the inflamed heart (Q92803859) (← links)
• Diabetes changes gene expression but not DNA methylation in cardiac cells (Q102071912) (← links)